UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10073, pp. 1025 - 1034
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Risk Assessment - methods | Coronary Artery Disease - surgery | Myocardial Infarction - mortality | Humans | Middle Aged | Kaplan-Meier Estimate | Treatment Outcome | Coronary Artery Disease - mortality | Ticlopidine - analogs & derivatives | Randomized Controlled Trials as Topic | Purinergic P2Y Receptor Antagonists - adverse effects | Multicenter Studies as Topic | Aspirin - adverse effects | Ticlopidine - adverse effects | Aged, 80 and over | Aged | Hemorrhage - chemically induced | Drug Therapy, Combination | Myocardial Infarction - etiology | Stents | Percutaneous Coronary Intervention | Platelet Aggregation Inhibitors - adverse effects | Medical policy | Complications and side effects | Medical research | Medical colleges | Aspirin | Clinical trials | Medicine, Experimental | Cardiology | Medicine, Preventive | Stent (Surgery) | Preventive health services | Anticoagulants | Heart attacks | Cardiovascular disease | Hemorrhage | Thrombosis | Patients | Risk assessment | Coronary vessels | Clinical medicine | Acute coronary syndromes | Age | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 388, Issue 10056, pp. 2142 - 2152
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Blood Pressure | Stroke | Humans | Middle Aged | Hypertension - drug therapy | Male | Treatment Outcome | Coronary Artery Disease - mortality | Antihypertensive Agents - therapeutic use | Hypotension - complications | Myocardial Infarction | Hypotension - mortality | Coronary Artery Disease - complications | Female | Aged | Cohort Studies | Hypertension | Medical research | Patient outcomes | Analysis | Mortality | Cardiac patients | Medicine, Experimental | Blood pressure | France | Coronary heart disease | Cardiovascular agents | Studies | Cardiovascular disease | Health risk assessment | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2017, Volume 389, Issue 10087, pp. 2383 - 2392
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Male | Tomography, X-Ray Computed | Aortic Valve - surgery | Prosthesis Design | Four-Dimensional Computed Tomography | Thrombosis - diagnostic imaging | Aged, 80 and over | Female | Registries | Thrombosis - prevention & control | Transcatheter Aortic Valve Replacement - adverse effects | Echocardiography | Aortic Valve - diagnostic imaging | Heart Valve Prosthesis - adverse effects | Aortic Valve - physiopathology | Bioprosthesis - adverse effects | Anticoagulants - therapeutic use | Heart Valve Diseases - etiology | Heart Valve Diseases - prevention & control | Thrombosis - etiology | Aged | Prosthesis Failure - etiology | Transcatheter Aortic Valve Replacement - methods | Heart Valve Diseases - diagnostic imaging | Heart valve diseases | Thrombosis | Blood clot | Heart | Anticoagulants | Therapy | Prostheses | Stroke | Warfarin | Demography | Funding | Heart surgery | Patients | Clinical outcomes | Prevention | Demographics | Computed tomography | Surgery | Imaging | Coronary vessels | Tomography | Hemodynamics | Lesions | Thromboembolism | Aortic valve | Medical imaging | Heart attacks | Heart valves | Data collection | Aorta | Mercury | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9740, pp. 517 - 523
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Biological and medical sciences | General aspects | Medical sciences | Prevention and actions | Pyrazoles - therapeutic use | Double-Blind Method | Mental Disorders - chemically induced | Obesity - drug therapy | Cannabinoid Receptor Antagonists | Cardiovascular Diseases - prevention & control | Humans | Male | Drug Approval | Suicide | Piperidines - therapeutic use | Piperidines - adverse effects | Aged, 80 and over | Cardiovascular Diseases - mortality | Female | Aged | Gastrointestinal Diseases - chemically induced | Pyrazoles - adverse effects | Prevention | Cardiovascular diseases | Research | Fees & charges | Data collection | Cardiovascular disease | Medical imaging | Clinical medicine | Diabetes | Index Medicus | Abridged Index Medicus | Drugs | Side effects | Hospitals | Mortality | myocardial infarction | suicide | vascular diseases | clinical trials | stroke
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2013, Volume 382, Issue 9909, pp. 1981 - 1992
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | General aspects | Diseases of the cardiovascular system | Biological and medical sciences | Medical sciences | Coronary heart disease | Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) | Double-Blind Method | Humans | Middle Aged | Male | Treatment Outcome | Adenosine Monophosphate - therapeutic use | Cause of Death | Randomized Controlled Trials as Topic | Myocardial Infarction - therapy | Graft Occlusion, Vascular - etiology | Percutaneous Coronary Intervention - methods | Adenosine Monophosphate - analogs & derivatives | Coronary Disease - therapy | Myocardial Ischemia - therapy | Acute Coronary Syndrome - therapy | Female | Myocardial Revascularization - statistics & numerical data | Aged | Hemorrhage - chemically induced | Platelet Aggregation Inhibitors - therapeutic use | Stents | Cangrelor | Drug therapy | Angioplasty | Patient outcomes | Heart attacks | Blood platelets | Coronary vessels | Acute coronary syndromes | Thrombosis | Veins & arteries | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2013, Volume 382, Issue 9892, pp. 605 - 613
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | Cardiovascular system | Radiodiagnosis. Nmr imagery. Nmr spectrometry | General aspects | Investigative techniques, diagnostic techniques (general aspects) | Biological and medical sciences | Medical sciences | Coronary heart disease | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Myocardial Infarction - mortality | Stroke - prevention & control | Ticlopidine - therapeutic use | Humans | Middle Aged | Risk Factors | Angina, Unstable - mortality | Kaplan-Meier Estimate | Acute Coronary Syndrome - mortality | Male | Treatment Outcome | Piperazines - therapeutic use | Ticlopidine - analogs & derivatives | Acute Coronary Syndrome - drug therapy | Coronary Angiography | Myocardial Infarction - drug therapy | Angina, Unstable - drug therapy | Female | Aged | Myocardial Infarction - prevention & control | Platelet Aggregation Inhibitors - therapeutic use | Heart attacks | Medical imaging | Heart surgery | Coronary vessels | Acute coronary syndromes | Drug dosages | Patients | Veins & arteries | Index Medicus | Abridged Index Medicus
Journal Article
The lancet. Diabetes & endocrinology, ISSN 2213-8587, 2015, Volume 3, Issue 5, pp. 356 - 366
Endocrinology & Metabolism | Other | Life Sciences & Biomedicine | Science & Technology | Hypoglycemic Agents - therapeutic use | Heart Failure - complications | Humans | Middle Aged | Risk Factors | Aged | Diabetes Mellitus, Type 2 - drug therapy | Heart Failure - epidemiology | Hypoglycemic Agents - adverse effects | Heart Failure - chemically induced | Diabetes Mellitus, Type 2 - epidemiology | Randomized Controlled Trials as Topic | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2013, Volume 382, Issue 9892, pp. 633 - 643
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiology. Vascular system | Heart | General aspects | Diseases of the cardiovascular system | Biological and medical sciences | Medical sciences | Coronary heart disease | Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) | Myocardial Infarction - surgery | Platelet Membrane Glycoprotein IIb - drug effects | Administration, Oral | Integrin beta3 - drug effects | Humans | Infusions, Parenteral | Anticoagulants - therapeutic use | Combined Modality Therapy | Adenosine Monophosphate - therapeutic use | Myocardial Infarction - drug therapy | Myocardial Reperfusion | Adenosine Monophosphate - administration & dosage | Adenosine Monophosphate - analogs & derivatives | Platelet Aggregation Inhibitors - administration & dosage | Thrombolytic Therapy | Platelet Aggregation Inhibitors - therapeutic use | Percutaneous Coronary Intervention | Acute coronary syndromes | Thrombosis | Heart attacks | Index Medicus | Abridged Index Medicus
Journal Article